Adamas Pharmaceuticals OverviewAdamas Pharmaceuticals Operating Income
Operating Income for ADMS.
Quarterly Operating Income
$-5636000.00
↓ 35.7% YoY
As of Sep 30, 2021
Annual Operating Income (TTM)
$-39293000.00
↓ 19.39% YoY
Trailing 12 months ending Sep 30, 2021